RNA Interference Inhibits Growth and Metastasis of Glioma Cells

Strategic Insights -

Recent research from Shanghai, China, has shown that RNA interference (RNAi) targeting the c-Met gene can effectively inhibit the growth and metastasis of glioma cells. The study, conducted by researchers at Shanghai Jiao Tong University, used RNAi technology to downregulate the expression of c-Met, a receptor tyrosine kinase involved in cellular proliferation, motility, and angiogenesis. The results demonstrated that RNAi of c-Met can significantly inhibit the growth and metastasis of glioma U251 cells, while also inducing cell apoptosis.

Key Takeaways:

  • The study demonstrated that RNAi targeting c-Met can effectively inhibit the growth and metastasis of glioma cells.
  • The expression of c-Met was inhibited by up to 90% in U251 cells using RNAi technology.
  • The inhibition of c-Met expression led to a decrease in cell growth, adherence, and invasion.
  • The study also showed that RNAi of c-Met can induce apoptosis in U251 cells.
  • The results indicate that RNAi of c-Met can be an effective antiangiogenic strategy for glioma.
  • The study provides evidence for the potential use of c-Met-targeted RNAi as a treatment for glioma.
  • Researchers at Shanghai Jiao Tong University, led by S.H. Chu, conducted the study.
  • The study was published in the Journal of Neuro-Oncology in 2009.

Statistics:

  • The expression of c-Met was inhibited by up to 90% in U251 cells using RNAi technology (RT-PCR).
  • The inhibition rate for c-Met expression was 79% by immunofluorescence staining and 85% by western blotting.
  • The study showed that RNAi of c-Met can inhibit cell growth by up to 67% (methyl thiazole tetrazolium assay).
  • The study demonstrated that RNAi of c-Met can induce apoptosis in U251 cells by up to 50% (flow cytometer).
  • The study was conducted in vitro using glioma U251 cells.

Sources:

  • Chu, S.H., et al. (2009). c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro. Journal of Neuro-Oncology, 93(2), 183-189.
  • RNA Research.